GlassScriptPhysician profile
Kapil Bhatia
NPI 1619408119
$29,111.15
in general payments reported to CMS, 2019-2025
9 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $138 · 2023: $628 · 2024: $28K · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $24K · Travel and Lodging: $2,844 · Food and Beverage: $1,864 · Education: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $23,500.00 |
| Travel and Lodging | $2,844.21 |
| Food and Beverage | $1,863.73 |
| Education | $540.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,200.92 | 2021-2025 | Ensite Precision, Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Medtronic, INC. | $10,481.02 | 2022-2025 | Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $1,462.19 | 2023-2024 | Versacross Access Solution, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $574.32 | 2022-2025 | Lifevest |
| Biosense Webster, INC. | $174.59 | 2024 | Carto 3 |
| Volta Medical INC | $134.92 | 2024 | Vx1 |
| Abiomed | $30.84 | 2023 | Impella |
| Biotronik INC. | $26.75 | 2025 | Solia |
| Recor Medical INC | $25.60 | 2024 | Paradise Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kapil Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.